Form 4: Cingulate Inc. Executive Vice President and COO, Laurie Myers, Reports Stock Option Grant

Laurie Myers, EVP and COO of Cingulate Inc., reports the acquisition of stock options.

Summary

• On March 4, 2024, Laurie Myers, the Executive Vice President and COO of Cingulate Inc., reported a transaction related to the company's stock.
• Myers acquired 26,056 stock options with an exercise price of $1.18.
• These options vest with 50% vesting on the six-month anniversary of the grant date, and the remaining shares vesting in substantially equal monthly installments over the following 30-month period.
• The options expire on March 4, 2034.
• Following the reported transaction, Myers directly owns 26,056 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The grant of stock options to a key executive aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in the pharmaceutical industry, aligning executive incentives with company performance and shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
• The vesting schedule of 50% after six months and the remainder over 30 months is fairly typical, designed to incentivize long-term performance.
• Comparable companies often use similar vesting schedules and option terms to retain and motivate key personnel.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the executive to improve company performance.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

stock options, Cingulate Inc., Form 4, Laurie Myers, executive compensation, beneficial ownership, CING